tradingkey.logo

Simulations Plus Inc

SLP
查看详细走势图
14.570USD
+0.430+3.04%
收盘 02/06, 16:00美东报价延迟15分钟
293.54M总市值
亏损市盈率 TTM

Simulations Plus Inc

14.570
+0.430+3.04%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.04%

5天

-13.74%

1月

-23.28%

6月

+3.63%

今年开始到现在

-20.08%

1年

-59.83%

查看详细走势图

TradingKey Simulations Plus Inc股票评分

单位: USD 更新时间: 2026-02-06

操作建议

Simulations Plus Inc当前公司基本面数据相对非常健康,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗设备与耗材行业排名70/205位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价24.75。中期看,股价处于下降通道。近一个月,市场表现非常差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Simulations Plus Inc评分

相关信息

行业排名
70 / 205
全市场排名
185 / 4521
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Simulations Plus Inc亮点

亮点风险
Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
业绩高增长
公司营业收入稳步增长,连续3年增长32.90%
业绩增长期
公司处于发展阶段,最新年度总收入79.18M美元
业绩转亏
公司业绩转亏,最新年度亏损美元
估值低估
公司最新PE估值-4.56,处于3年历史低位
机构减仓
最新机构持股15.79M股,环比减少20.73%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值1.66K
活跃度降低
近期活跃度降低,过去20天平均换手率0.61

分析师目标

根据 7 位分析师
买入
评级
24.750
目标均价
+67.00%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Simulations Plus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Simulations Plus Inc简介

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
公司代码SLP
公司Simulations Plus Inc
CEOO'Connor (Shawn M)
网址https://www.simulations-plus.com/
KeyAI